Biological therapy of systemic lupus erythematodus - focused on belimubab

Abstract

Belimubab is the first biological drug approved in the USA Canada and Europe for the treatment of systemic lupus erythematodus and the first new drug for this indication after more than fifty years.

Keywords

• Belimubab
• biological therapy
• systemic lupus erythematodes
• BLyS
• BAFF